In conclusion, in ESCC, the expression levels of DRP-1, ezrin and E-cadherin were all reduced, and this reduction or absence of expression may have been attributed to ESCC tumorigenesis and progression. This evidence concerns the gene CDH1 and esophageal squamous cell carcinoma.